Pregnancy Associated with Systemic Lupus Erythematosus: Immune Tolerance in Pregnancy and Its Deficiency in Systemic Lupus Erythematosus - An Immunological Dilemma

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Gluhovschi, Cristina ^a   Gluhovschi, Gheorghe ^a   Petrica, Ligia ^a   Velciov, Silvia ^a   Gluhovschi, Adrian ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD16 ANTIGEN; DOUBLE STRANDED DNA; ESTROGEN; FETAL ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; PHOSPHOLIPID ANTIBODY; PROGESTERONE;

B LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FETUS DEATH; FETUS WASTAGE; HUMAN; HUMORAL IMMUNITY; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOLOGICAL MONITORING; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOID CELL; MACROPHAGE; MONOCYTE; MOTHER FETUS RELATIONSHIP; NEWBORN DISEASE; PANCREAS ISLET DELTA CELL; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY DISORDER; PREGNANT WOMAN; REGULATORY T LYMPHOCYTE; REVIEW; STILLBIRTH; SUPPRESSOR CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; THROMBOCYTOPENIA; ANIMAL; IMMUNE SYSTEM; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATION;

ANIMALS; FEMALE; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; T-LYMPHOCYTES, REGULATORY;

EID: 84930958477     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/241547     Document Type: Review

References (94)

1. V. R. Aluvihare, M. Kallikourdis, and A. G. Betz, "Regulatory T cells mediate maternal tolerance to the fetus," Nature Immunology, vol. 5, no. 3, pp. 266-271, 2004.
2. G. Mor and I. Cardenas, "The immune system in pregnancy- a unique complexity," The American Journal of Reproductive Immunology, vol. 63, no. 6, pp. 425-433, 2010.
3. E. Kassi and P. Moutsatsou, "Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus," Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 317452, 14 pages, 2010.
4. L. E. Munoz, U. S. Gaipl, G. L. Grossmayer et al., "Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus," Arthritis & Rheumatism, vol. 60, no. 6, pp. 1733-1742, 2009.
5. J. Ernerudh, G. Berg, and J.Mjösberg, "Regulatory T helper cells in pregnancy and their roles in systemic versus local immune tolerance," The American Journal of Reproductive Immunology, vol. 66, supplement 1, pp. 31-43, 2011.
6. A. N. Baer, F. R. Witter, and M. Petri, "Lupus and pregnancy," Obstetrical and Gynecological Survey, vol. 66, no. 10, pp. 639-653, 2011.
7. S. Saito, A. Nakashima, T. Shima, and M. Ito, "Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy," American Journal of Reproductive Immunology, vol. 63, no. 6, pp. 601-610, 2010.
8. E. V. Lourenço and A. La Cava, "Natural regulatory T cells in autoimmunity," Autoimmunity, vol. 44, no. 1, pp. 33-42, 2011.
9. + regulatory T cells in human lupus erythematosus," Archives of Dermatological Research, vol. 301, no. 1, pp. 71-81, 2009.
10. E. Maggi, L. Cosmi, F. Liotta, P. Romagnani, S. Romagnani, and F. Annunziato, "Thymic regulatory T cells," Autoimmunity Reviews, vol. 4, no. 8, pp. 579-586, 2005.
11. C. Tower, I. Crocker, D. Chirico, P. Baker, and I. Bruce, "SLE and pregnancy: the potential role for regulatory T cells," Nature Reviews Rheumatology, vol. 7, no. 2, pp. 124-128, 2011.
12. + cells in SLE," Arthritis Research & Therapy, vol. 12, no. 1, article 110, 2010.
13. S. Varghese, I. Crocker, I. N. Bruce, and C. Tower, "Systemic lupus erythematosus, regulatory T cells and pregnancy," Expert Review of Clinical Immunology, vol. 7, no. 5, pp. 635-648, 2011.
14. E. Bettelli, T. Korn, and V. K. Kuchroo, "Th17: the third member of the effector T cell trilogy," Current Opinion in Immunology, vol. 19, no. 6, pp. 652-657, 2007.
15. T. Korn, E. Betelli, M. Oukka, and V. K. Kichroo, "IL-17 and Th17 cells," Annual Review of Immunology, vol. 27, pp. 485-517, 2009.
16. B. Fu, Z. Tian, and H. Wei, "Th17 cells in human recurrent pregnancy loss and pre-eclampsia," Cellular & Molecular Immunology, vol. 11, no. 6, pp. 564-570, 2014.
17. Y. K. Lee, R. Mukasa, R. A. Matton, and C. T. Weaver, "Developmental plasticity of Th17 and Treg cells," Current Opinion in Immunology, vol. 21, no. 3, pp. 274-280, 2009.
18. M. Torricelli, F. Bellisai, R. Novembri et al., "High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus," The American Journal of Reproductive Immunology, vol. 66, no. 2, pp. 84-89, 2011.
19. D. Khan, R. Dai, E. Karpuzoglu, and S. A. Ahmed, "Estrogen increases, whereas IL-27 and IFN-γ decrease, splenocyte IL-17 production in WT mice," European Journal of Immunology, vol. 40, no. 9, pp. 2549-2556, 2010.
20. B. Polese, V. Gridelet, E. Araklioti, H. Martens, S. Perrier d'Hauterive, and V. Geenen, "The endocrine milieu and CD4 T-lymphocyte polarization during pregnancy," Frontiers in Endocrinology, vol. 5, article 106, 2014.
21. A. M. Tyagi, K. Srivastava, M. N. Mansoori, R. Trivedi, N. Chattopadhyay, and D. Singh, "Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis," PLoS ONE, vol. 7, no. 9, Article ID e44552, 2012.
22. A. Nakashima, M. Ito, T. Shima, N. D. Bac, T. Hidaka, and S. Saito, "Accumulation of IL-17-positive cells in decidua of inevitable abortion cases," American Journal of Reproductive Immunology, vol. 64, no. 1, pp. 4-11, 2010.
23. Y.-S. Liu, L. Wu, X.-H. Tong et al., "Study on the relationship between Th17 cells and unexplained recurrent spontaneous abortion," The American Journal of Reproductive Immunology, vol. 65, no. 5, pp. 503-511, 2011.
24. A. Tsur, G. C. Hughes, Y. Shoenfeld, and H. Carp, "Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications," Immunologic Research, vol. 61, no. 1-2, pp. 31-34, 2015.
25. S. Lasarte, D. Elsner, M. Guía-González et al., "Female sex hormones regulate the Th17 immune response to sperm and Candida albicans," Human Reproduction, vol. 28, no. 12, pp. 3283-3291, 2013.
26. F. Fettke, A. Schumacher, S.D. Costa, and A. C. Zenclussen, "B cells: the old new player in reproductive immunology," Frontiers in Immunology, vol. 23, no. 5, article 285, 2014.
27. D. Aït-Azzouzene, M.-C. Gendron, M. Houdayer et al., "Maternal B lymphocytes specific for paternal histocompatibility antigens are partially deleted during pregnancy," Journal of Immunology, vol. 161, no. 6, pp. 2677-2683, 1998.
28. J. Anolik, I. Sanz, and R. J. Looney, "B cell depletion therapy in systemic lupus erythematosus," Current Rheumatology Reports, vol. 5, no. 5, pp. 350-356, 2003.
29. D. Muzzio, A. C. Zenclussen, and F. Jensen, "The role of B cells in pregnancy: the good and the bad," The American Journal of Reproductive Immunology, vol. 69, no. 4, pp. 408-412, 2013.
30. S. R. Sangle, P. M. K. Lutalo, R. J. Davies, M. A. Khamashta, and D. P. D'Cruz, "B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases," Journal of Autoimmunity, vol. 43, pp. 55-59, 2013.
31. W. Maidhof and O. Hilas, "Lupus: an overview of the disease and management options," Pharmacy and Therapeutics, vol. 37, no. 4, pp. 240-246, 2012.
32. J. P. Buyon and R. M. Clancy, "Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach," Seminars in Arthritis and Rheumatism, vol. 33, no. 3, pp. 140-154, 2003.
33. Z. Ulcova-Gallova, A. Mockova, and M. Cedikova, "Screening tests of reproductive immunology in systemic lupus erythematosus," Autoimmune Diseases, vol. 2012, Article ID 812138, 6 pages, 2012.
34. A. Tincani, D. Bompane, E. Danieli, and A. Doria, "Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome)," Lupus, vol. 15, no. 3, pp. 156-160, 2006.
35. D. Le Thi Thuong, N. Tieulié, N. Costedoat et al., "The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 in 15 women," Annals of the Rheumatic Diseases, vol. 64, no. 2, pp. 273-278, 2005.
36. M. D. Lockshin, M. L. Druzin, S. Goei et al., "Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus," The New England Journal of Medicine, vol. 313, no. 3, pp. 152-156, 1985.
37. H. P. McNeil, C. N. Chesterman, and S. A. Krilis, "Immunology and clinical importance of antiphospholipid antibodies," Advances in Immunology, vol. 49, pp. 193-280, 1991.
38. J. P. Hayslett, "The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome," American Journal of Reproductive Immunology, vol. 28, no. 3-4, pp. 199-204, 1992.
39. D. W. Branch, A. M. Peaceman, M. Druzin et al., "Amulticenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy," The American Journal of Obstetrics and Gynecology, vol. 182, no.1 I, pp. 122-127, 2000.
40. S. Koyasu and K. Moro, "Role of innate lymphocytes in infection and inflammation," Frontiers in Immunology, vol. 3, article 101, 2012.
41. T.-J. Kim, V. Upadhyay, V. Kumar, K.-M. Lee, and Y.-X. Fu, "Innate lymphoid cells facilitate NK development through a lymphotoxin-mediated stromal microenvironment," Journal of Experimental Medicine, vol. 211, no. 7, pp. 1421-1431, 2014.
42. A. Poggi and M. R. Zocchi, "NK cell autoreactivity and autoimmune diseases," Frontiers in Immunology, vol. 5, article 27, 2014.
43. A. C. Pereira, M. C. B. dos Santos Lima, N. R. de Jesús, M. M. França, H. da Silva Nahum Jr., and R. A. Levy, "NK cells in pregnant patients with SLE: a preliminary study," Revista Brasileira de Reumatologia, vol. 49, no. 4, pp. 387-401, 2009.
44. A. G. Baxter and M. J. Smyth, "The role of NK cells in autoimmune disease," Autoimmunity, vol. 35, no. 1, pp. 1-14, 2002.
45. Y. Su, S. Hong, and A. Zhao, "The changes of T lymphocyte subsets and serum interleukin-2 receptor in peripheral blood of the pregnant women complicated by systemic lupus erythematosus," Zhonghua Fu Chan Ke Za Zhi, vol. 32, no. 11, pp. 671-673, 1997.
46. L. Lunghi, B. Pavan, C. Biondi et al., "Use of glucocorticoids in pregnancy," Current Pharmaceutical Design, vol. 16, no. 32, pp. 3616-3637, 2010.
47. C.-C. Yeh, K.-C. Chao, and S. J. Huang, "Innate immunity, decidual cells, and preeclampsia," Reproductive Sciences, vol. 20, no. 4, pp. 339-353, 2013.
48. I. Manaster and O. Mandelboim, "The unique properties of human NK cells in the uterine mucosa," Placenta, vol. 29, pp. 60-66, 2008.
49. I. T. González, G. Barrientos, N. Freitag et al., "Uterine NK cells are critical in shaping DC immunogenic function compatible with pregnancy progression," PLoS ONE, vol. 7, no. 10, Article ID e46755, 2012.
50. A. Wallace, G. S. Whitley, B.Thilaganathan, and J. E. Corturight, "Decidual natural killer cell receptor expression is altered in pregnancies with impaired vascular remodeling and a higher risk of pre-eclampsia," Journal of Leukocyte Biology, vol. 97, no. 1, pp. 79-86, 2015.
51. M. D. Hazenberg and H. Spits, "Human innate lymphoid cells," Blood, vol. 124, no. 5, pp. 700-709, 2014.
52. M. Cherrier and G. Eberl, "The development of LTi cells," Current Opinion in Immunology, vol. 24,no. 2, pp. 178-183, 2012.
53. P. Vacca, E. Montaldo, D. Croxatto et al., "Identification of diverse innate lymphoid cells in human decidua," Mucosal Immunology, vol. 8, no. 2, pp. 254-264, 2015.
54. K. D. Heyborne, R. L. Cranfill, S. R. Carding, W. K. Born, and R. L. O'Brien, "Characterization of γδ T lymphocytes at the maternal-fetal interface," Journal of Immunology, vol. 149, no. 9, pp. 2872-2878, 1992.
55. J. Szekeres-Bartho, A. Barakonyi, B. Polgar et al., "The role of γ/δ T cells in progesterone-mediated immunomodulation during pregnancy: a review," American Journal of Reproductive Immunology, vol. 42, no. 1, pp. 44-48, 1999.
56. B. Polgar, A. Barakonyi, I. Xynos, and J. Szekeres-Bartho, "The role of γ/δ T cell receptor positive cells in pregnancy," The American Journal of Reproductive Immunology, vol. 41,no. 4, pp. 239-244, 1999.
57. D. Su, M. Shen, X. Li, and L. Sun, "Roles of gamma/delta T cells in pathogenesis of autoimmune diseases," Clinical and Developmental Immunology, vol. 2013, Article ID 985753, 6 pages, 2013.
58. T. Fujii, M. Okada, and J. Craft, "Regulation of T cell-dependent autoantibody production by a γδ T cell line derived from lupusprone mice," Cellular Immunology, vol. 217, no. 1-2, pp. 23-35, 2002.
59. S. Björkander, G. Heidari-Hamedani, K. Bremme, I. Gunnarsson, and U. Holmlund, "Peripheral monocyte expression of the chemokine receptors CCR2, CCR5 and CXCR3 is altered at parturition in healthy Women and in women with systemic lupus erythematosus," Scandinavian Journal of Immunology, vol. 77, no. 3, pp. 200-212, 2013.
60. M. M. Faas, F. Spaans, and P. de Vog, "Monocytes and macrophages in pregnancy and pre-eclampsia," Frontiers in Immunology, vol. 5, article 298, 2014.
61. A. K. Palucka, J. Banchereau, P. Blanco, and V. Pascual, "The interplay of dendritic cell subsets in systemic lupus erythematosus," Immunology and Cell Biology, vol. 80, no. 5, pp. 484-488, 2002.
62. E. Tagliani and A. Erlebacher, "Dendritic cell function at the maternal-fetal interface," Expert Review of Clinical Immunology, vol. 7, no. 5, pp. 593-602, 2011.
63. J. H. Fransen, J. V. D. Vlag, J. Ruben, G. J. Adema, J. H. Berden, and L. B. Hilbrands, "The role of dendritic cells in the pathogenesis of systemic lupus erythematosus," Arthritis Research and Therapy, vol. 12, no. 2, article 207, 2010.
64. L. J. Jara, G. T. Romero-Sanchez, L. A. Montiel-Cervantes et al., "Dendritic cells and regulatory T CD4CD25Bright in pregnant patients with systemic lupus erythematosus," Arthritis & Rheumatism, vol. 62, supplement 10, p. 1150, 2010.
65. F. Tanriverdi, L. F. G. Silveira, G. S. MacColl, and P. M. G. Bouloux, "The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity," Journal of Endocrinology, vol. 176, no. 3, pp. 293-304, 2003.
66. M. Cutolo, A. Sulli, B. Seriolo, S. Accardo, and A. T. Masi, "Estrogens, the immune response and autoimmunity," Clinical and Experimental Rheumatology, vol. 13, no. 2, pp. 217-226, 1995.
67. A. Doria, L. Iaccarino, P. Sarzi-Puttini et al., "Estrogens in pregnancy and systemic lupus erythematosus," Annals of the New York Academy of Sciences, vol. 1069, pp. 247-256, 2006.
68. 2 response is decreased during pregnancy in systemic lupus erythematosus," Reumatismo, vol. 64, no. 5, pp. 314-320, 2012.
69. N. Kanda, T. Tsuchida, and K. Tamaki, "Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus," Arthritis & Rheumatism, vol. 42, no. 2, pp. 328-337, 1999.
70. J. F. G. Cohen-Solal, V. Jeganathan, L. Hill et al., "Hormonal regulation of B-cell function and systemic lupus erythematosus," Lupus, vol. 17, no. 6, pp. 528-532, 2008.
71. M. Zen, A. Ghirardello, L. Iaccarino et al., "Hormones, immune response, and pregnancy in healthy women and SLE patients," Swiss Medical Weekly, vol. 140, no. 13-14, pp. 187-201, 2010.
72. G. C. Hughes and D. Choubey, "Modulation of autoimmune rheumatic diseases by oestrogen and progesterone," Nature Reviews Rheumatology, vol. 10, pp. 740-751, 2014.
73. M.-R. Du, S.-C. Wang, and D.-J. Li, "The integrative roles of chemokines at the maternal-fetal interface in early pregnancy," Cellular and Molecular Immunology, vol. 11, no. 5, pp. 438-448, 2014.
74. A. Blaschitz, H. Hutter, and G. Dohr, "HLA Class I protein expression in the human placenta," Early Pregnancy, vol. 5, no. 1, pp. 67-69, 2001.
75. M. D. Lockshin and L. R. Sammaritano, "Lupus pregnancy," Autoimmunity, vol. 36, no. 1, pp. 33-40, 2003.
76. R. Nayar and J. M. Lage, "Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosuswith antiphospholipid syndrome: a case report and review of the literature," Human Pathology, vol. 27, no. 2, pp. 201-206, 1996.
77. J. G. Hanly, D. D. Gladman, T. H. Rose, C. A. Laskin, and M. B. Urowitz, "Lupus pregnancy. A prospective study of placental changes," Arthritis and Rheumatism, vol. 31, no. 3, pp. 358-366, 1988.
78. J. P. Hayslett, "Maternal and fetal complications in pregnant women with systemic lupus erythematosus," American Journal of Kidney Diseases, vol. 17, no. 2, pp. 123-126, 1991.
79. A. Melk, G. Mueller-Eckhardt, B. Polten, A. Lattermann, O. Heine, and O. Hoffmann, "Diagnostic and prognostic significance of anticardiolipin antibodies in patients with recurrent spontaneous abortions," The American Journal of Reproductive Immunology, vol. 33, no. 3, pp. 228-233, 1995.
80. F. Qureshi, Y. Yang, S. M. Jacques et al., "Anti-DNA antibodies cross-reacting with laminin inhibit trophoblast attachment and migration: implications for recurrent pregnancy loss in SLE patients," American Journal of Reproductive Immunology, vol. 44, no. 3, pp. 136-142, 2000.
81. M. E. B. Clowse, L. S.Magder, F.Witter, and M. Petri, "Early risk factors for pregnancy loss in lupus," Obstetrics and Gynecology, vol. 107, no. 2, pp. 293-299, 2006.
82. V. Saini, S. Arora, A. Yadav, and J. Bhattacharjee, "Cytokines in recurrent pregnancy loss," Clinica Chimica Acta, vol. 412, no. 9-10, pp. 702-708, 2011.
83. K. L. Hon and A. K. C. Leung, "Neonatal lupus erythematosus," Autoimmune Diseases, vol. 2012, Article ID 301274, 6 pages, 2012.
84. J. P. Buyon and R. M. Clancy, "Neonatal lupus syndromes," Current Opinion in Rheumatology, vol. 15, no. 5, pp. 535-541, 2003.
85. M. Boutjdir, L. Chen, Z.-H. Zhang, C.-E. Tseng, N. El-Sherif, and J. P. Buyon, "Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model," Pediatric Research, vol. 44, no. 1, pp. 11-19, 1998.
86. W. Wisuthsarewong, J. Soongswang, and R. Chantorn, "Neonatal lupus erythematosus: clinical character, investigation, and outcome," Pediatric Dermatology, vol. 28,no. 2, pp. 115-121, 2011.
87. 1-ribonucleoprotein antibodies in patients with connective tissue diseases," Clinical and Experimental Immunology, vol. 126, no. 2, pp. 345-354, 2001.
88. M. Shahian, A. Khosravi, and M.-H. Anbardar, "Early cholestasis in neonatal lupus erythematosus," Annals of Saudi Medicine, vol. 31, no. 1, pp. 80-82, 2011.
89. O. Meyer, "Making pregnancy safer for patients with lupus," Joint Bone Spine, vol. 71, no. 3, pp. 178-182, 2004.
90. D. Elish and N. B. Silverberg, "Neonatal lupus erythematosus," Cutis, vol. 77, no. 2, pp. 82-86, 2006.
91. J. T. Repke, "Hypertensive disorders of pregnancy. Differentiating preeclampsia from active systemic lupus erythematosus," Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 43, no. 4, pp. 350-354, 1998.
92. A. Perez-Sepulveda, M. J. Torres, M. Khoury, and S. F. Illanes, "Innate immune system and preeclampsia," Frontiers in Immunology, vol. 5, p. 244, 2014.
93. A. Fatemi, R. M. Fard, Z. Sayedbonakdar, Z. Farajzadegan, and M. Saber, "The role of lupus nephritis in development of adverse maternal and fetal outcomes during pregnancy," International Journal of Preventive Medicine, vol. 4, no. 9, pp. 1004-1010, 2013.
94. G. Ruiz-Irastorza, F. Lima, J.Alves et al., "Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies," British Journal of Rheumatology, vol. 35, no. 2, pp. 133-138, 1996.